In Kyrgyzstan, a combination of recombinant recEm95 antigen with EmP antigen for the diagnosis of AE seems to be suitable, with a combined sensitivity of 98% and a specificity of 87% in the ultrasound–negative population. The gene discussed is MAEA; the disease is acrodermatitis enteropathica.